Recent improvements to enhance your investment research experience
360° View free for everyone
Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.
3 new subscription models
Plans for every investor - from stock ideas to in-depth analysis.
Similar Stocks
Four stock alternatives to the stock you're searching.
The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.
Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.
| Metrics | Current | 2024 | 2023 | 2022 |
|---|---|---|---|---|
|
Value
|
8 | 11 | 24 | 21 |
|
Growth
|
49 | 100 | 23 | 1 |
|
|
14 | 14 | 16 | 20 |
|
Sentiment
|
20 | 78 | 78 | 34 |
|
|
19 | 19 | 1 | 4 |
| Metrics | Current | 2024 | 2023 | 2022 |
|---|---|---|---|---|
|
Analyst Opinions
|
66 | 93 | 93 | 46 |
|
Opinions Change
|
1 | 50 | 50 | 50 |
|
Pro Holdings
|
n/a | 70 | 55 | 62 |
|
Market Pulse
|
69 | 40 | 59 | 25 |
|
Sentiment
|
20 | 78 | 78 | 34 |
| Metrics | Current | 2024 | 2023 | 2022 |
|---|---|---|---|---|
|
Value
|
8 | 11 | 24 | 21 |
|
Growth
|
49 | 100 | 23 | 1 |
|
Safety
|
14 | 14 | 16 | 20 |
|
Combined
|
6 | 6 | 1 | 1 |
| Metrics | Current | 2024 | 2023 | 2022 |
|---|---|---|---|---|
|
Price vs. Sales (P/S)
|
40 | 40 | 40 | 40 |
|
Price vs. Earnings (P/E)
|
13 | 3 | 30 | 15 |
|
Price vs. Book (P/B)
|
7 | 7 | 19 | 40 |
|
Dividend Yield
|
1 | 1 | 1 | 1 |
|
Value
|
8 | 11 | 24 | 21 |
| Metrics | Current | 2024 | 2023 | 2022 |
|---|---|---|---|---|
|
Revenue Growth
|
94 | 85 | 89 | 71 |
|
Profit Growth
|
12 | 73 | 13 | 1 |
|
Capital Growth
|
31 | 84 | 1 | 19 |
|
Stock Returns
|
51 | 100 | 45 | 23 |
|
Growth
|
49 | 100 | 23 | 1 |
| Metrics | Current | 2024 | 2023 | 2022 |
|---|---|---|---|---|
|
Leverage
|
100 | 61 | 60 | 3 |
|
Refinancing
|
41 | 12 | 49 | 69 |
|
Liquidity
|
6 | 6 | 6 | 39 |
|
Safety
|
14 | 14 | 16 | 20 |
Discover high‑ranked alternatives to ClearPoint Neuro and broaden your portfolio horizons.
USA
USA
The Obermatt Advantage
Choose the Obermatt subscription that best fits your needs.
Top 10 Market ListsSimilar Stocks1 WatchlistDelivered to your inboxTop 10 Market ListsSimilar Stocks
Stock Filters6 key ranks for 6,500+ stocks3 WatchlistsDelivered to your inboxTop 10 Market ListsSimilar StocksStock FiltersInvestment Themes6 key ranks for 6,500+ stocks15 more detailed ranks3 years of historical ranksUnlimited WatchlistsDelivered to your inbox
30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.
Add to Watchlist
See Similar Stocks
